| J3262 | Injection, tocilizumab, 1 mg | 63,760 | $10 | $318.8K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 28,650 | $10 | $315.1K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 5,650 | $30 | $175.2K |
| J0897 | Injection, denosumab, 1 mg | 8,820 | $20 | $158.8K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 4,540 | $30 | $118K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 820 | $90 | $75K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 470 | $100 | $45.6K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 210 | $130 | $25.9K |
| 86235 | The lab analyst performs an assay to evaluate the patient’s serum for each antibody to an extractable nuclear antigen, also called ENA. Types of ENA antibodies include anti ribonuclear protein,… | 880 | $20 | $15.8K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 190 | $50 | $10K |